Overview
- The Global Burden of Disease 2023 analysis, published in JAMA on July 30, 2026, estimated elevated low-density lipoprotein cholesterol (LDL-C) caused 3.6 million deaths and 90.7 million disability-adjusted life years in 2023.
- Nearly one third of ischemic heart disease deaths and more than one quarter of ischemic stroke deaths worldwide were attributed to high LDL-C, making it a leading modifiable driver of heart attacks and strokes.
- Age-standardized death and DALY rates for LDL-C fell by roughly 40–46% since 1990, but total deaths and healthy years lost rose about 38.5% because of population growth and aging.
- The burden is concentrated in middle- and low-income settings, with India and China accounting for about 34% of global DALYs, a pattern linked to low screening rates and uneven access to statins and newer lipid-lowering treatments.
- High LDL-C is usually symptomless but detectable with a simple lipid blood test and often treatable with lifestyle changes and affordable drugs; experts are urging earlier routine screening, broader statin access, and public-health measures to cut saturated fats and processed foods.